MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 167,609 Shares of National Health Investors, Inc. $NHI

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. has reduced its stake in National Health Investors, Inc. by 43.0%, now owning 222,507 shares, valued at approximately $16.4 million.
• National Health Investors recently announced an increase in its quarterly dividend to $0.92, representing an annualized dividend of $3.68 and a dividend yield of 4.6%.
• The company's stock has shown a 1.4% increase, reaching $79.16, with analysts setting an average price target of $84.20 for the shares.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 43.0% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 222,507 shares of the real estate investment trust's stock after selling 167,609 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.48% of National Health Investors worth $16,434,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Millennium Management LLC raised its stake in National Health Investors by 1,967.0% in the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock worth $33,843,000 after purchasing an additional 464,727 shares in the last quarter. Land & Buildings Investment Management LLC grew its holdings in National Health Investors by 109.4% during the 4th quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock worth $32,367,000 after acquiring an additional 243,999 shares during the last quarter. MetLife Investment Management LLC grew its holdings in National Health Investors by 706.6% during the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust's stock worth $15,786,000 after acquiring an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. bought a new stake in National Health Investors during the 1st quarter worth approximately $10,340,000. Finally, Nuveen LLC acquired a new position in shares of National Health Investors in the 1st quarter worth approximately $10,126,000. Institutional investors and hedge funds own 62.51% of the company's stock.

National Health Investors Price Performance

NYSE:NHI traded down $0.90 during mid-day trading on Friday, reaching $78.20. The stock had a trading volume of 307,322 shares, compared to its average volume of 184,418. The stock has a market capitalization of $3.71 billion, a P/E ratio of 24.98, a P/E/G ratio of 3.36 and a beta of 0.76. National Health Investors, Inc. has a one year low of $65.13 and a one year high of $86.13. The firm has a 50 day moving average price of $74.15 and a two-hundred day moving average price of $73.53. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, topping the consensus estimate of $1.16 by $0.06. The firm had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business's revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $1.18 earnings per share. As a group, analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a dividend yield of 4.7%. National Health Investors's payout ratio is presently 115.02%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, August 27th. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. Finally, Truist Financial increased their target price on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, National Health Investors currently has an average rating of "Buy" and an average target price of $84.20.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.